by Alex Bajjon | May 1, 2019 | Briefings, UK
Background The patent in question (EP 1173181) related to a new dosage regime for tadalafil (marketed under the brand name Cialis®) for treating erectile dysfunction (ED). The patent is owned by ICOS and exclusively licensed to Eli Lilly. The claims of the patent...
by Sean Hughes | May 1, 2019 | Briefings, EPO
Background As previously reported, in G 2/12 (Broccoli and Tomatoes II), the Enlarged Board of Appeal found that Article 53(b) EPC did not exclude plants produced by essentially biological processes from patentability. Nevertheless, following guidance from the...
by Carolyn Haywood | May 1, 2019 | Briefings, EPO
The Broad Institute (Broad) manages a patent portfolio on behalf of several collaborating institutions, including Broad, Massachusetts Institute of Technology (MIT), and President and Fellows of Harvard College (Harvard) which contains several European patents for...
by Carolyn Haywood | May 1, 2019 | Briefings, EPO
The Broad Institute (Broad) manages a patent portfolio on behalf of several collaborating institutions, including Broad, Massachusetts Institute of Technology (MIT), and President and Fellows of Harvard College (Harvard) which contains several European patents for...
by Sean Hughes | Mar 1, 2019 | Briefings, UK
Background The Patent in question related to a method of producing platelet rich plasma (PRP) from whole blood. The inventive concept was said to reside in a resuspension step that allowed preparation of PRP from whole blood using only one centrifugation step. The...
by Carolyn Haywood | Mar 1, 2019 | Briefings, Designs & Copyright, Trademarks, UK
The updated guidance note on Brexit and IP provided by the UKIPO makes it clear that the aim of the Government is still for Brexit to cause as little disruption as possible with respect to IP rights. However, despite a ‘no-deal’ Brexit being voted down earlier this...
Recent Comments